CAR T-cell therapy tested in SwedenSeptember 18, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin Lymphoma
Plant-derived compound shows activity against NHLSeptember 16, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EMA recommends orphan designation for CAR T-cell therapySeptember 13, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Blood cancer drugs set to be removed from CDFSeptember 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyALLMyelodysplastic Syndrome
FDA updates warning about TreandaSeptember 6, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Team reports latest results of CTL019 in CLLSeptember 3, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
How malaria increases the risk of Burkitt lymphomaAugust 14, 2015Lymphoma & Plasma Cell DisordersRelated IssuesNon-Hodgkin Lymphoma
New prognostic model for follicular lymphomaAugust 13, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
How CLL evades the immune systemAugust 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Topical gel appears safe, effective in CTCLAugust 7, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug gets orphan designation for CTCLAugust 5, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Health Canada grants drug conditional approval for MCLJuly 31, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Tool identifies optimal TKI for cancersJuly 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesNon-Hodgkin Lymphoma
Analysis reveals ‘distinctive biology’ of CTCLJuly 30, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma